Alignment Healthcare (NASDAQ:ALHC) CEO Sells $3,688,200.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John Kao sold 180,000 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $20.49, for a total value of $3,688,200.00. Following the sale, the chief executive officer owned 2,652,641 shares in the company, valued at $54,352,614.09. The trade was a 6.35% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Alignment Healthcare Price Performance

Shares of ALHC traded down $0.13 during midday trading on Tuesday, reaching $20.63. The stock had a trading volume of 2,193,751 shares, compared to its average volume of 2,997,888. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99. The company has a market capitalization of $4.13 billion, a price-to-earnings ratio of -171.92, a price-to-earnings-growth ratio of 5.29 and a beta of 1.16. The company’s 50-day moving average is $20.85 and its 200 day moving average is $17.96. Alignment Healthcare, Inc. has a 12-month low of $11.63 and a 12-month high of $23.87.

Analyst Upgrades and Downgrades

ALHC has been the subject of several recent research reports. Zacks Research downgraded shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 28th. TD Cowen increased their target price on Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a report on Friday, January 16th. Robert W. Baird set a $28.00 price target on Alignment Healthcare in a research report on Friday, January 30th. Piper Sandler boosted their price objective on Alignment Healthcare from $20.00 to $30.00 and gave the company an “overweight” rating in a research report on Tuesday, January 6th. Finally, Wall Street Zen raised Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Alignment Healthcare has a consensus rating of “Moderate Buy” and an average target price of $23.32.

Institutional Investors Weigh In On Alignment Healthcare

Institutional investors and hedge funds have recently modified their holdings of the stock. Royal Bank of Canada raised its stake in Alignment Healthcare by 92.6% in the first quarter. Royal Bank of Canada now owns 92,379 shares of the company’s stock worth $1,720,000 after buying an additional 44,413 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Alignment Healthcare by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,557 shares of the company’s stock worth $1,109,000 after acquiring an additional 2,594 shares in the last quarter. Goldman Sachs Group Inc. raised its position in shares of Alignment Healthcare by 79.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 972,715 shares of the company’s stock worth $18,112,000 after acquiring an additional 429,703 shares in the last quarter. Woodline Partners LP purchased a new position in shares of Alignment Healthcare in the 1st quarter valued at approximately $2,142,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Alignment Healthcare by 16.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 307,655 shares of the company’s stock valued at $5,729,000 after purchasing an additional 44,452 shares in the last quarter. 86.19% of the stock is owned by hedge funds and other institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.